An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions

References

1. 1.↵
   1. Radü EW,
   2. Sahraian MA

   , eds. MRI Atlas of MS Lesions. Berlin: Springer-Verlag; 2008
2. 2.↵
   2. Barkhof F

   . The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002;15:239–45 doi:10.1097/00019052-200206000-00003 pmid:12045719

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Popescu V,
   3. Agosta F,
   4. Hulst HE, et al

   ; MAGNIMS Study Group. Brain atrophy and lesion load predict long term disability in multiple sclerosis. J Neurol Neurosurg Psychiatry 2013;84:1082–91 doi:10.1136/jnnp-2012-304094 pmid:23524331

   Abstract/FREE Full Text
4. 4.↵
   2. Calabresi PA,
   3. Radue EW,
   4. Goodin D, et al

   . Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Neurol 2014;13:545–56 doi:10.1016/S1474-4422(14)70049-3 pmid:24685276

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Thompson AJ,
   3. Kermode AG,
   4. MacManus DG, et al

   . Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ. 1990;300:631–34 doi:10.1136/bmj.300.6725.631 pmid:2138923

   Abstract/FREE Full Text
6. 6.↵
   2. Brex PA,
   3. Ciccarelli O,
   4. O'Riordan JI, et al

   . A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158–64 doi:10.1056/NEJMoa011341 pmid:11796849

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Khoury SJ,
   3. Guttmann CR,
   4. Orav EJ, et al

   . Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology 1994;44:2120–24 doi:10.1212/WNL.44.11.2120 pmid:7969970

   Abstract/FREE Full Text
8. 8.↵
   2. Rudick RA,
   3. Lee JC,
   4. Simon J, et al

   . Significance of T2 lesions in multiple sclerosis: a 13-year longitudinal study. Ann Neurol 2006;60:236–42 doi:10.1002/ana.20883 pmid:16786526

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Zivadinov R,
   3. Zorzon M,
   4. De Masi R, et al

   . Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. J Neurol Sci 2008;267:28–35 doi:10.1016/j.jns.2007.09.025 pmid:17945260

   CrossRefPubMed
10. 10.↵
    2. Harris JO,
    3. Frank JA,
    4. Patronas N, et al

    . Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991;29:548–55 doi:10.1002/ana.410290515 pmid:1859184

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Guttmann CR,
    3. Rousset M,
    4. Roch JA, et al

    . Multiple sclerosis lesion formation and early evolution revisited: a weekly high-resolution magnetic resonance imaging study. Mult Scler J 2016;22:761–69 doi:10.1177/1352458515600247 pmid:26362901

    CrossRefPubMed
12. 12.↵
    2. Gaitán MI,
    3. Shea CD,
    4. Evangelou IE, et al

    . Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol 2011;70:22–29 doi:10.1002/ana.22472 pmid:21710622

    CrossRefPubMed
13. 13.↵
    2. Sweeney EM,
    3. Shinohara RT,
    4. Dewey BE, et al

    . Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions. Neuroimage Clin 2016;10:1–17 doi:10.1016/j.nicl.2015.10.013 pmid:26693397

    CrossRefPubMed
14. 14.↵
    2. Fonov V,
    3. Evans AC,
    4. Botteron K, et al

    ; Brain Development Cooperative Group. Unbiased average age-appropriate atlases for pediatric studies. Neuroimage 2011;54:313–27 doi:10.1016/j.neuroimage.2010.07.033 pmid:20656036

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Avants B,
    3. Tustison N,
    4. Song G, et al

    . ANTS: Advanced Open-Source Normalization Tools for Neuroanatomy. Philadelphia: Penn Image Computing and Science Laboratory; 2009
16. 16.↵
    2. Carass A,
    3. Wheeler MB,
    4. Cuzzocreo J, et al

    . A joint registration and segmentation approach to skull stripping. In: Proceedings of the 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, Arlington, Virgina. April 12–15, 2007:656–59. http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=4193371. Accessed April 1, 2016.
17. 17.↵
    2. Shinohara RT,
    3. Sweeney EM,
    4. Goldsmith J, et al

    ; Australian Imaging Biomarkers Lifestyle Flagship Study of Ageing, Alzheimer's Disease Neuroimaging Initiative. Statistical normalization techniques for magnetic resonance imaging. Neuroimage Clin 2014;6:9–19 doi:10.1016/j.nicl.2014.08.008 pmid:25379412

    CrossRefPubMed
18. 18.↵
    2. Sweeney EM,
    3. Shinohara RT,
    4. Shiee N, et al

    . OASIS is Automated Statistical Inference for Segmentation, with applications to multiple sclerosis lesion segmentation in MRI. Neuroimage Clin 2013;2:402–13 doi:10.1016/j.nicl.2013.03.002 pmid:24179794

    CrossRefPubMed
19. 19.↵
    2. Shinohara RT,
    3. Oh J,
    4. Nair G, et al

    ; NAIMS Cooperative. Volumetric analysis from a harmonized multisite brain MRI study of a single subject with multiple sclerosis. AJNR Am J Neuroradiol 2017;38:1501–09 doi:10.3174/ajnr.A5254 pmid:28642263

    Abstract/FREE Full Text
20. 20.↵
    2. Jenkinson M,
    3. Pechaud M,
    4. Smith S

    . BET2: MR-based estimation of brain, skull and scalp surfaces. Oxford: Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB); 2005. http://mickaelpechaud.free.fr/these/HBM05.pdf. Accessed June 13, 2016.
21. 21.↵
    2. Valcarcel AN,
    3. Linn KA,
    4. Vandekar SN, et al

    . MIMoSA: a method for inter-modal segmentation analysis. June 15, 2017. bioRxiv 150284 doi:10.1101/150284
22. 22.↵
    2. Sweeney EM,
    3. Shinohara RT,
    4. Shea CD, et al

    . Automatic lesion incidence estimation and detection in multiple sclerosis using multisequence longitudinal MRI. AJNR Am J Neuroradiol 2013;34:68–73 doi:10.3174/ajnr.A3172 pmid:22766673

    Abstract/FREE Full Text
23. 23.↵
    2. Papinutto N,
    3. Bakshi R,
    4. Bischof A, et al

    ; North American Imaging in Multiple Sclerosis Cooperative (NAIMS). Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1-weighted brain MRI acquisitions. Magn Reson Med 2018;79:1595–601 doi:10.1002/mrm.26776 pmid:28617996

    CrossRefPubMed
24. 24.↵
    2. Oh J,
    3. Bakshi R,
    4. Calabresi PA

    ; NAIMS Cooperative Steering Committee. The NAIMS cooperative pilot project: Design, implementation and future directions. Mult Scler 2017 Oct 1. [Epub ahead of print] doi:10.1177/1352458517739990 pmid:29106329

    CrossRefPubMed
25. 25.↵
    2. Meier DS,
    3. Guttmann CR

    . Time-series analysis of MRI intensity patterns in multiple sclerosis. Neuroimage 2003;20:1193–209 doi:10.1016/S1053-8119(03)00354-9 pmid:14568488

    CrossRefPubMed
26. 26.↵
    2. Meier DS,
    3. Guttmann CR

    . MRI time series modeling of MS lesion development. Neuroimage 2006;32:531–37 doi:10.1016/j.neuroimage.2006.04.181 pmid:16806979

    CrossRefPubMed